|
Dib, Amel; Glebov, Oleg K; Shou, Yaping et al. (2009) A der(8)t(8;11) chromosome in the Karpas-620 myeloma cell line expresses only cyclin D1: yet both cyclin D1 and MYC are repositioned in close proximity to the 3'IGH enhancer. DNA Repair (Amst) 8:330-5
|
|
Dib, Amel; Gabrea, Ana; Glebov, Oleg K et al. (2008) Characterization of MYC translocations in multiple myeloma cell lines. J Natl Cancer Inst Monogr :25-31
|
|
Chng, W J; Kuehl, W M; Bergsagel, P L et al. (2008) Translocation t(4;14) retains prognostic significance even in the setting of high-risk molecular signature. Leukemia 22:459-61
|
|
Bergsagel, P Leif; Kuehl, W Michael (2008) WSU-WM and BCWM.1 should not be assumed to represent Waldenstrom macroglobulinemia cell lines. Blood 112:917
|
|
Kuehl, W Michael (2008) Modeling multiple myeloma by AID-dependent conditional activation of MYC. Cancer Cell 13:85-7
|
|
Gabrea, Ana; Martelli, Maria Luisa; Qi, Ying et al. (2008) Secondary genomic rearrangements involving immunoglobulin or MYC loci show similar prevalences in hyperdiploid and nonhyperdiploid myeloma tumors. Genes Chromosomes Cancer 47:573-90
|
|
Dib, Amel; Barlogie, Bart; Shaughnessy Jr, John D et al. (2007) Methylation and expression of the p16INK4A tumor suppressor gene in multiple myeloma. Blood 109:1337-8
|
|
Keats, Jonathan J; Fonseca, Rafael; Chesi, Marta et al. (2007) Promiscuous mutations activate the noncanonical NF-kappaB pathway in multiple myeloma. Cancer Cell 12:131-44
|
|
Lenz, Georg; Nagel, Inga; Siebert, Reiner et al. (2007) Aberrant immunoglobulin class switch recombination and switch translocations in activated B cell-like diffuse large B cell lymphoma. J Exp Med 204:633-43
|
|
Annunziata, Christina M; Davis, R Eric; Demchenko, Yulia et al. (2007) Frequent engagement of the classical and alternative NF-kappaB pathways by diverse genetic abnormalities in multiple myeloma. Cancer Cell 12:115-30
|
Showing the most recent 10 out of 19 publications
